Chinese experts develop noninvasive tumor therapy
BEIJING -- Chinese experts developed a noninvasive tumor therapy with high performance and low side effects, according to a report by Science and Technology Daily.
The research published in Advanced Therapeutics was jointly carried out by the Nanjing Medical University and Grahope New Materials (GNM), a company focusing on the research and development of graphene technology.
The study found that a specific far-infrared ray generated from a single-layer graphene-based device can effectively suppresses tumor growth and spread of cancer cells and prolongs survival in tumor-bearing mice.
Compared with the carbon fiber device, the graphene-based device produced by GNM can emit a far-infrared ray with strong penetration, which is the reason why it can speed up the death of cancer cells.
"The innovative research and application of the graphene-based device provide cancer patients with a creative treatment method which enjoys broad clinical prospects," Ren Yahui, former chief physician of Baoding No 1 Hospital of Traditional Chinese Medicine in North China's Hebei province, was quoted by the report as saying.
- China weighs draft amendment to cybersecurity law to better promote, regulate sound AI development
- China's progress, new opportunities for the world
- Zhengzhou inks friendly cooperation with 4 intl cities
- Five-Year Review! Explore foreigners' perceptions of China's economy
- High school entrance exam will remain, education authorities clarify
- Education ministry unveils measures to improve students' mental health































